• By ICR Secretariat
  • Posted Thursday, June 10, 2021

Regeneron leaps ahead in COVID-19 antibody race, scoring FDA nod for lower dose and subcutaneous injection

https://www.fiercepharma.com/pharma/fda-gives-regeneron-a-shot-arm-making-its-covid-19-antibody-treatment-more-user-friendly

When Eli Lilly gained emergency use approval for its COVID-19 antibody treatment last October, it was a major triumph for a company aiming to satisfy a desperate need around the world.